Journal List > J Korean Ophthalmol Soc > v.52(10) > 1008898

Jeon, Lee, and Na: The Clinical Outcomes of 23-Gauge Transconjunctival Sutureless Vitrectomy for Endophthalmitis after Cataract Surgery

Abstract

Purpose

To report the clinical outcomes and utility of 23-gauge (G) transconjunctival sutureless vitrectomy (TSV) in patients with postoperative endophthalmitis following cataract surgery.

Methods

The medical records of 16 patients (17 eyes) who underwent 23-G TSV between January 2008 and December 2009 at Konyang University Hospital due to postoperative endophthalmitis following cataract surgery were retrospectively analyzed. The pre- and post-operative best-corrected visual acuities (BCVA), changes in intraocular pressure, the time from diagnosis to surgery, the intraoperative and postoperative complications, and the average duration of hospitalization were investigated.

Results

The mean BCVA significantly improved from log MAR 1.89 ± 1.03 to log MAR 0.42 ± 0.82 (p = 0.001), and the mean intraocular pressure changed from 16.1 ± 4.1 mm Hg at baseline to 16.2 ± 3.3 mm Hg on the first postoperative day without any significant difference (p = 0.955). In addition, none of the patients required sutures to treat wound leakage or showed hypotony on follow-up observation. The average operation time was 64.7 ± 22.5 minutes, and the average duration of hospitalization was 5.4 ± 4.5 days.

Conclusions

The use of 23-G TSV in patients with postoperative endophthalmitis following cataract surgery may offer more convenience for the surgeon and more comfort for the patient. In addition, the patient may return to normal life earlier with a shortened duration of hospitalization.

References

1. Puliafito CA, Baker AS, Haaf J, Foster CS. Infectious endophthalmitis. Review of 36 cases. Ophthalmology. 1982; 89:921–9.
2. Eckardt C. Transconjunctival sutureless 23-gauge vitrectomy. Retina. 2005; 25:208–11.
crossref
3. Aaberg TM Jr, Flynn HW Jr, Schiffman J, Newton J. Nosocomial acute-onset postoperative endophthalmitis survey. A 10 year review of incidence and outcomes. Ophthalmology. 1998; 105:1004–10.
4. Schmitz S, Dick HB, Krummenauer F, Pfeiffer N. Endophthalmitis in cataract surgery; results of a German survey. Ophthalmology. 1999; 106:1869–77.
5. Barry P, Seal DV, Gettinby G, et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study. J Cataract Refract Surg. 2006; 32:407–10.
6. Maquire JI. Postoperative endophthalmitis: optimal management and the role and timing of vitrectomy surgery. Eye. 2008; 22:1290–300.
crossref
7. Nagaki Y, Hayasaka S, Kadoi C, et al. Bacterial endothalmitis after small-incision cataract surgery: effect of incision placement and intraocular lens type. J Cataract Refract Surg. 2003; 29:20–6.
8. Cooper BA, Holekamp NM, Bohigian G, Thompson PA. Case-control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear corneal wounds. Am J Ophthalmol. 2003; 136:300–5.
crossref
9. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995; 113:1479–96.
10. Doft BH, Kelsey SF, Wisniewski S, et al. Treatment of endophthalmitis after cataract extraction. Retina. 1994; 14:297–304.
crossref
11. Han JI, Cho SW, Lee TG, et al. The clinical results of sutureless vitrectomy using 23-gauge surgical system. J Korean Ophthalmol Soc. 2008; 49:911–6.
crossref
12. Woo SJ, Park KH, Hwang JM, et al. Risk factors associated with sclerotomy leakage and postoperative hypotony after 23-gauge transconjunctival sutureless vitrectomy. Retina. 2009; 29:456–63.
crossref
13. Laatikainen L, Tarkkanen A. Early vitrectomy in the treatment of postoperative purulent endophthalmitis. Acta Ophthalmol. 1987; 65:455–60.
crossref
14. Kuhn F, Gini G. Ten years after. Are findings of the Endophthalmitis Vitrectomy Study still relevant today? Graefes Arch Clin Exp Ophthalmol. 2005; 243:1197–9.
15. Kim SH, Kim JS. A case of Agrobacterium radiobacter endophthalmitis following cataract surgery. J Korean Ophthalmol Soc. 2001; 42:1117–21.
16. Johnson MW, Doft BH, Kelsey SF, et al. The endophthalmitis Vitrectomy Study, Relationship between clinical presentation and microbiologic spectrum. Ophthalmology. 1997; 104:261–72.
17. Lee SB, Han JW, Chung SK, Baek NH. Factors associated with visual outcomes of postoperative endophthalmitis following cataract surgery. J Korean Ophthalmol Soc. 2005; 46:1618–23.
18. Kim WJ, Kweon EY, Lee DW, Cho NC. Postoperative endophthalmitis following cataract surgery over an eight-year period. J Korean Ophthalmol Soc. 2008; 49:1771–8.
crossref
19. Jung J-Y, Ko BY, Kim BY. Factors associated with a poor visual result in acute endophthalmitis after cataract surgery. J Korean Ophthalmol Soc. 2008; 49:1242–7.
crossref

Figure 1.
The pre- and post-operative visual acuity.
jkos-52-1167f1.tif
Figure 2.
Time from diagnosis to initiation of surgery.
jkos-52-1167f2.tif
Table 1.
Distribution and demographic characteristics of the patients
Case No. Age Sex Culture PreOP* BCVA PostOP BCVA (6 mon) PreOP IOP§ (mm Hg) PostOP IOP (mm Hg) PreOP INJ PostOP INJ Hospitalization (day) Operation time (min) Remark
1 57 F No growth HM 0.4 11 15 0 0 4 90
2 57 F No growth FC 1.0 10 16 0 0 4 105
3 74 F 0.06 0.8 21 16 0 0 2 40
4 39 F No growth 0.1 1.0 25 26 1 0 8 70
5 58 F 0.2 1.0 18 18 1 0 2 55 Endolaser
6 68 M HM 1.0 15 15 1 0 5 115 Post capsulotomy, Endolaser
7 70 F Staphylococcus epidermidis 0.2 1.0 16 13 0 0 3 55
8 26 M HM 1.0 16 20 1 0 3 75
9 78 F No growth # 0.03 0.3 13 11 1 1 3 52 Previous posterior capsular rupture
10 52 F Pantoea spp.# 0.1 0.8 10 13 0 0 6 65
11 83 M No growth HM FC 20 16 1 1 6 80 Vitreous flushing Macular degeneration
12 55 F No growth 0.1 0.6 11 15 1 0 7 60
13 78 M HM 0.3 16 15 1 0 5 45
14 50 M FC 1.0 23 18 0 0 1 43
15 43 M 0.1 1.0 18 17 0 0 2 35
16 77 M Staphylococcus epidermidis HM HM 16 14 0 0 18 50 Macular infarction
17 63 M Staphylococcus epidermidis HM 0.5 15 17 0 0 14 65 Core vitrectomy

* PreOP = preoperative

BCVA = best-corrected visual acuity

PostOP = postoperative

§ IOP = intraocular pressure

INJ = intravitreal injection

# spp. = species.

TOOLS
Similar articles